13
Participants
Start Date
March 11, 2019
Primary Completion Date
July 15, 2020
Study Completion Date
August 12, 2020
Paltusotine
Paltusotine, capsules, once daily by mouth
Placebo
Placebo, capsules, once daily by mouth
The Research Institute of Dallas, Dallas
Ohio State University, Columbus
CETI - Centro de Estudos em Terapias Inovadoras, Curitiba
CPQuali Pesquisa Clinica, São Paulo
"General Hospital of Athens Gennimatas", Athens
Semmelweis University Faculty of Medicine, Budapest
University of Pécs Medical School, Pécs
Endocrine, Diabetes and Research Centre, Wellington Hospital, Wellington
The Centre of Postgraduate Medical Education, Warsaw
Clinical Centre Serbia, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Belgrade
National Institute of Endocrinology and Diabetology, Ľubochňa
Lead Sponsor
Crinetics Pharmaceuticals Inc.
INDUSTRY